June 21st

➡ An overview of the Global Inhalation Market, Leading Brands Indication and Sales for both Asthma and COPD and non-Asthma and COPD indications, Current Market and Indication Trends including Generics and Products in Late Stage Development
➡ Respiratory and Non-Respiratory Indications, Disease States with Increasing Global Burden, Prioritization of Therapeutic Strategies (Relevant Examples); Lung Architecture and the Lungs as a portal for Systemic Delivery; Overview of Pulmonary Drug Delivery Technology (Nebulizers, pMDIs, DPIs)
➡ The Case for Respirable Engineered Spray Dried Dry Powder, Pulmonary Particle Deposition using Gamma Scintigraphy and Systemic PK, Local Lung Delivery (Tobi Podhaler), Platform Approach and the 505(b)(2) Regulatory Pathway